Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HS-20118 tablets in adults with moderate to severe plaque psoriasis
CTR20261952Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-20118 in plaque psoriasis, sponsored by Hengrui Therapeutics. Started Jun 2026; status: active.
02
Drugs
HS-20118
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20261952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261952.